We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,307
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATLC icon
7776
Atlanticus Holdings
ATLC
$1.63B
$2K ﹤0.01%
260
BDL icon
7777
Flanigan's Enterprises
BDL
$82.9M
$2K ﹤0.01%
90
BDRX
7778
Biodexa Pharmaceuticals
BDRX
$1.35M
0
BLIN icon
7779
Bridgeline Digital
BLIN
$14.7M
$2K ﹤0.01%
+1,338
New +$2.14K
BYFC icon
7780
Broadway Financial
BYFC
$97.2M
$2K ﹤0.01%
+177
New +$2.21K
CAN
7781
Canaan Creative
CAN
$149M
$2K ﹤0.01%
+250
New +$1.68K
CANF
7782
Can-Fite BioPharma American Depositary Shares
CANF
$6.79M
$2K ﹤0.01%
+4
New +$2.15K
CARM
7783
DELISTED
Carisma Therapeutics
CARM
$2K ﹤0.01%
74
CHCI icon
7784
Comstock Holding Companies
CHCI
$148M
$2K ﹤0.01%
983
+770
+362% +$1.57K
CRTO icon
7785
CALL
Criteo S.A. Ordinary Shares
CRTO
$1.07B
$2K ﹤0.01%
100
-317,000
-100% -$5.64M
DUO
7786
Fangdd Network Group
DUO
$23.7M
0
ELDN icon
7787
Eledon Pharmaceuticals
ELDN
$265M
$2K ﹤0.01%
+206
New +$2.18K
EUDG icon
7788
WisdomTree Europe Quality Dividend Growth Fund
EUDG
$70M
$2K ﹤0.01%
63
-383
-86% -$10.1K
EWV icon
7789
ProShares Trust UltraShort MSCI Japan
EWV
$5.29M
$2K ﹤0.01%
19
-226
-92% -$22.3K
FCPI icon
7790
Fidelity Stocks for Inflation ETF
FCPI
$279M
$2K ﹤0.01%
+75
New +$1.92K
GIGM icon
7791
GigaMedia
GIGM
$15.4M
$2K ﹤0.01%
+915
New +$2.27K
GTN.A icon
7792
Gray Media Inc
GTN.A
$699M
$2K ﹤0.01%
86
GYRO icon
7793
Gyrodyne
GYRO
$12.1M
$2K ﹤0.01%
91
-1,015
-92% -$19.6K
HUSV icon
7794
First Trust Horizon Managed Volatility Domestic ETF
HUSV
$74.5M
$2K ﹤0.01%
+83
New +$2.27K
JMUB icon
7795
JPMorgan Municipal ETF
JMUB
$8.44B
$2K ﹤0.01%
+35
New +$1.9K
KWY
7796
Kingsway Corp
KWY
$265M
$2K ﹤0.01%
+838
New +$1.75K
LFT
7797
Lument Finance Trust
LFT
$35.9M
$2K ﹤0.01%
625
-4,800
-88% -$15.8K
LPCN icon
7798
Lipocine
LPCN
$17.4M
$2K ﹤0.01%
353
+294
+498% +$7.53K
MFDX icon
7799
PIMCO RAFI Multi-Factor International Equity ETF
MFDX
$465M
$2K ﹤0.01%
61
-81
-57% -$2.06K
MNA icon
7800
IQ ARB Merger Arbitrage ETF
MNA
$253M
$2K ﹤0.01%
51
-201
-80% -$6.56K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,307 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.